Reaction
Arteriovenous Fistula reporting signals
As of the last recalculation, Arteriovenous Fistula appears in 486 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 62.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 15 | 62.2 | 62.3 |
| Paricalcitol | 16 | 50.1 | 50.2 |
| Epoetin Alfa | 12 | 44.5 | 44.5 |
| Diltiazem Hydrochloride Extended-Release Tablets | 9 | 34.5 | 34.5 |
| Tamsulosin Hydrochloride | 14 | 30.2 | 30.2 |
| Basiliximab | 8 | 29.6 | 29.6 |
| Tizanidine | 14 | 25.8 | 25.9 |
| Prasugrel Hydrochloride | 5 | 21.3 | 21.3 |
| Minoxidil Foam 5% (Womens) | 7 | 9.2 | 9.2 |
| Minoxidil | 7 | 6.8 | 6.8 |
| Cinacalcet Hydrochloride | 6 | 5.6 | 5.6 |